drugset / Trial / NCT02921984
Concurrent Chemotherapy Based on Genetic Testing in Patients With High-Risk Salivary Gland Tumors
Phase 1
Completed
20 enrolled
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The role of postoperative concurrent chemotherapy (CCT) has not been established for salivary gland tumors (SGTs). This prospective study was conducted to evaluate the feasibility and safety of customized CCT regimens based on the gene targets of SGTs.
Timeline
- Start
- 2013-09
- Primary completion
- 2016-12
- Completion
- 2017-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 70 mg/m2 | — |
| Subject | Docetaxel | Small molecule | 80 mg/m2 | — |
| Subject | Pemetrexed | Small molecule | 500 mg/m2 | — |